GlassScriptPhysician profile
Mark A Oppenheim
NPI 1497117402
$4,058.92
in general payments reported to CMS, 2019-2025
19 companies · $95.00 in 2025
The $95.00 reported for 2025 was less than what a typical Oral and Maxillofacial Surgery provider received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,186 · 2020: $756 · 2021: $1,406 · 2022: $408 · 2023: $101 · 2024: $106 · 2025: $95.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $207 · Gift: $95.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $207.40 |
| Gift | $95.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $883.59 | 2019-2022 | |
| Stryker Corporation | $795.07 | 2019-2021 | |
| Biohorizons Implant Systems INC. | $546.81 | 2019-2021 | |
| Medical Device Business Services, INC. | $487.51 | 2020-2021 | |
| Axogen | $479.08 | 2020-2022 | |
| Straumann USA LLC | $174.96 | 2023-2025 | |
| Keystone Dental INC. | $145.20 | 2021 | |
| Kls-Martin L.P. | $118.25 | 2022 | |
| Zimmer Biomet Holdings, INC. | $87.03 | 2019-2021 | |
| Nobel Biocare USA | $62.44 | 2023 | Nobelactive |
| Integra Lifesciences Corporation | $52.42 | 2019-2020 | |
| Acera Surgical, INC. | $46.75 | 2019 | |
| Geistlich Pharma, North America, INC. | $45.30 | 2019 | |
| Cook Medical LLC | $38.40 | 2019 | |
| Zimvie INC. | $33.23 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $19.54 | 2020 | |
| Acumed LLC | $18.63 | 2023 | Osteomed |
| Dentsply Sirona INC | $13.14 | 2024 | Implant Dentistry |
| Checkpoint Surgical, INC | $11.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Oppenheim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.